Implications for Predictive Analytics from GDPR, SGB, and Other Regulations in Pharma - Learnings from MSD.
Tuesday, May 12, 2020
Pharma companies are realizing the benefits of using predictive analytics to optimize marketing campaigns and sales activities. But they are bound by GDPR and other laws, like all industries. On top of that, the healthcare industry faces additional regulations while pharma companies are generally very conservative. Sounds like a lost cause … unless the data science and legal teams collaborate to find approaches that meet both needs.MSD, a large pharma company, has developed a predictive analytics engine while addressing all legal and data privacy concerns. This session will show the limitations, approaches, and success factors for predictive analytics in pharma.